<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Loss of p53 is considered to allow progression of <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> from the <z:mpath ids='MPATH_270'>adenoma</z:mpath> to the <z:mp ids='MP_0002038'>carcinoma</z:mp> stage </plain></SENT>
<SENT sid="1" pm="."><plain>Using mice with an intestinal epithelial cell (IEC)-specific p53 deletion, we demonstrate that loss of p53 alone is insufficient to initiate intestinal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> but markedly enhances carcinogen-induced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> incidence and leads to <z:e sem="disease" ids="C0677898" disease_type="Neoplastic Process" abbrv="">invasive cancer</z:e> and lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Whereas p53 controls DNA damage and IEC survival during the initiation stage, loss of p53 during <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> is associated with increased intestinal permeability, causing formation of an NF-ÎºB-dependent inflammatory microenvironment and the induction of epithelial-mesenchymal transition </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, we propose a p53-controlled <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressive function that is independent of its well-established role in cell-cycle regulation, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and senescence </plain></SENT>
</text></document>